Combination therapies for treating cancer
US11622961B2 · kind B2 · utility
1Cited by
11References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2018 |
| Grant date | Apr 11, 2023 |
| Priority date | — |
| Expiry date | May 18, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of treatment for cancer(s) through combination therapy with an agent that inhibits poly [ADP-ribose] polymerase (PARP) signaling and an agent that regulates activity within the tumor microenvironment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.